Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $723.8700 (-0.15%) ($723.8700 - $723.8700) on Thu. Jan. 5, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.4% (three month average) | RSI | 36 | Latest Price | $723.8700(-0.15%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.3% a day on average for past five trading days. | Weekly Trend | REGN declines -0.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(50%) DIA(32%) SPLV(29%) IWD(28%) SDY(27%) | Factors Impacting REGN price | REGN will decline at least -0.7% in a week (0% probabilities). TBT(-13%) EDOC(-8%) URA(-6%) ARKG(-6%) VCSH(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.7% (StdDev 1.4%) | Hourly BBV | -0.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $732.28 | 5 Day Moving Average | $722.44(0.2%) | 10 Day Moving Average | $722.77(0.15%) | 20 Day Moving Average | $732.28(-1.15%) | To recent high | -5.5% | To recent low | 2.5% | Market Cap | $76.751b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |